Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Doxil Shortage Solution: FDA Chooses Middle Ground, Allows Import Of Unapproved Version

Executive Summary

FDA is allowing Sun Pharma Global FZE to import its unapproved liposomal version of doxorubicin, Lipodox, to alleviate a shortage, but has not yet given the drug full approval.

You may also be interested in...



Yesterday’s Solution; Tomorrow’s Problem

Two years ago, Sun Pharmaceuticals was a key part of FDA’s efforts in helping drug shortages; now FDA has banned imports from one of its plants.

Sun Pharmaceutical Aims To Keep Rivals In The Rearview Mirror

India’s Sun Pharmaceuticals says it is set to keep sales volumes growing in part through an aggressive acquisition strategy and a more diversified mix of products after third quarter profit more than quadruples.

Rx Imports Will Resolve Shortage Of Injectable Nutrition Drugs After Congressional Letter

Fresenius Kabi USA’s Norway plant is to supply the US with three injectable drugs used in total parenteral nutrition, primarily for treatment of premature infants; FDA has previously permitted importation of 11 other drugs that have been subject to shortages.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS054289

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel